Anti-BetaGamma, an innovative biomedical therapeutic, meticulously directs its focus towards the intricacies of the Beta and Gamma receptors ensconced within the enigmatic human body. Pioneering the treatment of multifarious neurological disorders, including but not limited to, Parkinson's disease and schizophrenia, this revolutionary elixir assumes the indispensable role of meticulously modulating these receptors to achieve optimal symptom management. By engendering a targeted and judicious bond with these receptors, Anti-BetaGamma bestows upon individuals afflicted with said conditions the potential for respite and relief, ameliorating their daily struggles with unparalleled efficacy and finesse.
CAT# | GR2202 |
M.F/Formula | C217H340N46O63 |
M.W/Mr. | 4601.29 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Etomidate, a highly selective intravenous anesthetic agent, was first synthesized at Janssen Pharmaceuticals in ...
Myristoyl hexapeptide-4, a stabilized peptide, is a synthetic peptide containing lysine, threonine and serine re ...
Elcatonin acetate, a physicochemically and biologically stable synthetic derivative of calcitonin transformed fr ...
Pramlintide is a synthetic analogue of pancreatic amyloid polypeptide. Pancreatic amyloid polypeptide is a polyp ...
Dynorphin A (1-13) [Dyn-A (1-13)] is a short-chain polypeptide containing 13 amino acids and having extensive bi ...